| Primary |
| Hormone Level Abnormal |
100.0% |
|
|
| Secondary |
| Menopausal Symptoms |
14.7% |
| Asthma |
8.4% |
| Asthmatic Crisis |
8.4% |
| Depression |
8.4% |
| Libido Decreased |
8.4% |
| Drug Use For Unknown Indication |
7.4% |
| Malnutrition |
5.3% |
| Vitamin Supplementation |
5.3% |
| Blood Cholesterol Increased |
4.2% |
| Product Used For Unknown Indication |
4.2% |
| Contraception |
3.2% |
| Headache |
3.2% |
| Hypertension |
3.2% |
| Osteoporosis |
3.2% |
| Anxiety |
2.1% |
| Cardiac Disorder |
2.1% |
| Ear Pain |
2.1% |
| Generalised Anxiety Disorder |
2.1% |
| Infection Prophylaxis |
2.1% |
| Premature Menopause |
2.1% |
|
| Weight Increased |
35.7% |
| Female Sexual Arousal Disorder |
21.4% |
| Uterine Leiomyoma |
14.3% |
| Myocardial Infarction |
7.1% |
| Rash |
7.1% |
| Rhabdomyolysis |
7.1% |
| Visual Acuity Reduced |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.4% |
| Drug Use For Unknown Indication |
18.5% |
| Hypopituitarism |
3.9% |
| Pain |
3.8% |
| Hormone Replacement Therapy |
3.6% |
| Acth Decreased |
3.5% |
| Nutritional Support |
3.4% |
| Blood Corticotrophin Decreased |
3.2% |
| Hypothyroidism |
3.1% |
| Hypogonadism |
2.5% |
| Hypertension |
2.5% |
| Primary Hypothyroidism |
2.3% |
| Bronchitis |
2.2% |
| Blood Follicle Stimulating Hormone Decreased |
2.1% |
| Blood Luteinising Hormone Decreased |
2.1% |
| Depression |
2.1% |
| Growth Hormone Deficiency |
1.9% |
| Hypogonadism Female |
1.9% |
| Thyroid Disorder |
1.9% |
| Follicle-stimulating Hormone Deficiency |
1.9% |
|
| Gastroenteritis |
9.6% |
| Weight Decreased |
8.7% |
| Weight Increased |
7.7% |
| Vomiting |
6.7% |
| Insomnia |
5.8% |
| Wound Infection |
5.8% |
| Pain In Extremity |
4.8% |
| Pulmonary Embolism |
4.8% |
| Brain Neoplasm |
3.8% |
| Flushing |
3.8% |
| Gastroenteritis Viral |
3.8% |
| Injection Site Pain |
3.8% |
| Muscular Weakness |
3.8% |
| Nausea |
3.8% |
| Pruritus |
3.8% |
| Skin Disorder |
3.8% |
| Somnolence |
3.8% |
| Tremor |
3.8% |
| Upper Respiratory Tract Infection |
3.8% |
| Urinary Tract Infection |
3.8% |
|
